GlassScriptPhysician profile
Niranjana Shah
NPI 1316910250
$1,497.76
in general payments reported to CMS, 2019-2025
11 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $19.90 · 2021: $252 · 2023: $385 · 2024: $299 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $273.07 | 2021-2023 | Tecentriq |
| Sanofi-Aventis U.S. LLC | $240.92 | 2023-2024 | |
| Abbvie INC. | $199.71 | 2023-2024 | Vraylar |
| Nevro Corp. | $125.00 | 2019 | |
| Intercept Pharmaceuticals, INC. | $120.65 | 2021 | |
| Phathom Pharmaceuticals, INC. | $110.10 | 2025 | Voquezna |
| Amarin Pharma, INC. | $107.26 | 2019 | |
| Evoke Pharma, INC. | $101.25 | 2025 | |
| Corcept Therapeutics | $100.90 | 2024 | Korlym |
| Alnylam Pharmaceuticals INC. | $99.00 | 2019 | |
| Ascensia Diabetes Care US INC. | $19.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niranjana Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.